Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of BLD-2660 versus placebo in hospitalized adults with COVID-19
RBR-2kjm6yPhase 2Recruiting
- Sponsor
- Blade Therapeutics, Inc.
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) and viral pneumonia comparing Placebo plus standard of care with BLD-2660 plus standard of care (2 arms). Started May 2020; status: recruiting.
02
Drugs
dazcapistat
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on RBR-2kjm6y.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2kjm6y.